The US administration has stopped mRNA vaccine development by terminating 22 federal contracts, sparking concerns from the World Health Organization about pandemic preparedness. WHO officials highlighted the importance of mRNA vaccines, noting their effectiveness during COVID and potential for rapid adaptation to emerging threats. Health Secretary Robert F Kennedy Jr explained that the decision was based on data indicating mRNA vaccines' ineffectiveness against upper respiratory infections like COVID and flu. WHO's Joachim Hombach emphasized the need for continued global development of mRNA vaccine technologies.
mRNA vaccines are a very important technology and platform which has served us extremely well for COVID. We also know there is very promising work going on in relation to influenza vaccines.
The platform is particularly useful in relation to developing vaccines against emerging and pandemic threats, because these platforms can be very rapidly adapted.
The US health department's Biomedical Advanced Research and Development Authority is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.
Hombach called for work on the development of mRNA vaccines to continue around the world.
Collection
[
|
...
]